Biperiden

Generic name
Biperiden
Brand name
ATC Code
N04AA02
Dosages
Side effects in children
Warnings & precautions in children
Contra-indications in children

Interactions
PK
Renal impairment
References

Pharmacokinetics in children

No information

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

Available formulations

No information is present at this moment.

Dosages

Extrapyramidal symptoms caused by medicines (e.g. haloperidol, metoclopramide, alizapride)
  • Intravenous
    • 1 month up to 18 years
      • 0.1 mg/kg/dose in 1 dose. Max: 5 mg/day. Administer slowly.
  • Oral
    • 3 years up to 18 years
      • 1 - 2 mg/dose 1-3x daily.

Renal impaiment in children > 3 months

No information available on dose adjustment in renal impairment.

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects in children

The safety profile in children and adolescents is similar to that of adults. [SmPC Akineton]

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications

No information available on specific contra indications in children.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions

No information available on specific warnings and precautions in children.

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

ANTICHOLINERGIC AGENTS

This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.

References

  1. Rademaker C.M.A. et al, Geneesmiddelen-Formularium voor Kinderen, 2007
  2. Laboratorio Farmaceutico, SPC Akineton (RVG 02196) 22-10-2014, www.cbg-meb.nl
  3. Desma GmbH, SmPC Akineton 5 mg Injektionslösung (91579.00.00), 02/2019

Changes

Therapeutic Drug Monitoring


Overdose